EXPO
EXPO
Exponent, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $147.43M ▲ | $6.71M ▼ | $24.76M ▼ | 16.8% ▼ | $0.49 ▼ | $36.64M ▼ |
| Q3-2025 | $147.12M ▲ | $7.65M ▲ | $28.04M ▲ | 19.06% ▲ | $0.55 ▲ | $41.15M ▲ |
| Q2-2025 | $141.96M ▼ | $6.14M ▼ | $26.55M ▼ | 18.7% ▲ | $0.52 | $34.32M ▼ |
| Q1-2025 | $145.51M ▲ | $93M ▲ | $26.65M ▲ | 18.32% ▲ | $0.52 ▲ | $40.25M ▲ |
| Q4-2024 | $136.77M | $5.74M | $23.59M | 17.25% | $0.46 | $33.82M |
What's going well?
Revenue is stable and the company keeps a healthy profit margin. Overhead costs are coming down, showing management is watching expenses.
What's concerning?
Profits and earnings per share are slipping, and gross margins are getting squeezed. Revenue growth is basically flat, so future gains may be hard to come by without new growth drivers.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $221.93M ▲ | $777.52M ▲ | $387.18M ▲ | $390.34M ▼ |
| Q3-2025 | $207.38M ▼ | $761.45M ▲ | $358.59M ▲ | $402.86M ▼ |
| Q2-2025 | $231.8M ▼ | $759.43M ▼ | $331.65M ▲ | $427.78M ▼ |
| Q1-2025 | $245.11M ▼ | $763.24M ▼ | $321.83M ▼ | $441.41M ▲ |
| Q4-2024 | $258.9M | $777.27M | $356.2M | $421.07M |
What's financially strong about this company?
EXPO has more than enough cash to cover all debts and bills, a high proportion of liquid assets, and a long history of profits. The company is even buying back shares, showing confidence in its future.
What are the financial risks or weaknesses?
Shareholder equity dipped slightly and payables dropped to zero, which could mean timing differences or aggressive bill payments. Otherwise, there are no major balance sheet concerns.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $24.76M ▼ | $55.58M ▲ | $-2.69M ▼ | $-38.4M ▲ | $14.55M ▲ | $52.9M ▲ |
| Q3-2025 | $28.04M ▲ | $32.65M ▼ | $-2.67M ▼ | $-54.51M ▼ | $-24.42M ▼ | $29.98M ▼ |
| Q2-2025 | $26.55M ▼ | $36.22M ▲ | $-2.27M ▼ | $-47.47M ▼ | $-13.31M ▲ | $33.95M ▲ |
| Q1-2025 | $26.65M ▲ | $7.27M ▼ | $-1.75M ▲ | $-20.05M ▼ | $-13.79M ▼ | $5.52M ▼ |
| Q4-2024 | $23.59M | $56.05M | $-2.6M | $-12.32M | $39.19M | $53.45M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
Engineering And Other Scientific | $110.00M ▲ | $120.00M ▲ | $120.00M ▲ | $250.00M ▲ |
Environmental And Health | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $40.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Exponent, Inc.'s financial evolution and strategic trajectory over the past five years.
Exponent combines steady revenue growth with high and resilient profitability, supported by strong cash generation and low capital intensity. Its balance sheet is conservative, with historically more cash than debt and growing retained earnings. The company operates in a defensible niche at the intersection of engineering, science, regulation, and litigation, where reputation, multidisciplinary expertise, and specialized testing facilities create meaningful barriers to entry. Consistent free cash flow has enabled rising dividends and shareholder returns without compromising core operations.
Key risks include a gradual tightening of liquidity as cash cushions shrink and leverage ticks up from very low levels, even if overall debt remains manageable. Margins at the project level have shown some pressure from rising delivery costs, and the absence of explicit R&D spending could become a concern if it signals underinvestment in new capabilities. The business is heavily dependent on the recruitment and retention of highly skilled experts, making talent a structural vulnerability. Demand can also fluctuate with litigation trends, regulatory shifts, and client budgets for risk and safety‑related consulting. Finally, any damage to the firm’s hard‑won reputation for objectivity and technical rigor would be difficult to repair.
The overall outlook appears favorable but not without caveats. Exponent is well placed to benefit from growing technological complexity, stricter regulation, and heightened focus on safety and reliability in areas like electrification, AI, digital health, and advanced energy systems. Its financial profile provides resilience and flexibility to invest in people and capabilities, even as the balance sheet becomes slightly less conservative. Future performance will hinge on maintaining strong margins, managing liquidity prudently, and continuing to deepen its expertise in emerging technologies. While past trends point to a stable, high‑quality business, outcomes will still depend on external factors such as regulatory environments, litigation volumes, and the pace of technological change in its end markets.
About Exponent, Inc.
https://www.exponent.comExponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $147.43M ▲ | $6.71M ▼ | $24.76M ▼ | 16.8% ▼ | $0.49 ▼ | $36.64M ▼ |
| Q3-2025 | $147.12M ▲ | $7.65M ▲ | $28.04M ▲ | 19.06% ▲ | $0.55 ▲ | $41.15M ▲ |
| Q2-2025 | $141.96M ▼ | $6.14M ▼ | $26.55M ▼ | 18.7% ▲ | $0.52 | $34.32M ▼ |
| Q1-2025 | $145.51M ▲ | $93M ▲ | $26.65M ▲ | 18.32% ▲ | $0.52 ▲ | $40.25M ▲ |
| Q4-2024 | $136.77M | $5.74M | $23.59M | 17.25% | $0.46 | $33.82M |
What's going well?
Revenue is stable and the company keeps a healthy profit margin. Overhead costs are coming down, showing management is watching expenses.
What's concerning?
Profits and earnings per share are slipping, and gross margins are getting squeezed. Revenue growth is basically flat, so future gains may be hard to come by without new growth drivers.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $221.93M ▲ | $777.52M ▲ | $387.18M ▲ | $390.34M ▼ |
| Q3-2025 | $207.38M ▼ | $761.45M ▲ | $358.59M ▲ | $402.86M ▼ |
| Q2-2025 | $231.8M ▼ | $759.43M ▼ | $331.65M ▲ | $427.78M ▼ |
| Q1-2025 | $245.11M ▼ | $763.24M ▼ | $321.83M ▼ | $441.41M ▲ |
| Q4-2024 | $258.9M | $777.27M | $356.2M | $421.07M |
What's financially strong about this company?
EXPO has more than enough cash to cover all debts and bills, a high proportion of liquid assets, and a long history of profits. The company is even buying back shares, showing confidence in its future.
What are the financial risks or weaknesses?
Shareholder equity dipped slightly and payables dropped to zero, which could mean timing differences or aggressive bill payments. Otherwise, there are no major balance sheet concerns.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $24.76M ▼ | $55.58M ▲ | $-2.69M ▼ | $-38.4M ▲ | $14.55M ▲ | $52.9M ▲ |
| Q3-2025 | $28.04M ▲ | $32.65M ▼ | $-2.67M ▼ | $-54.51M ▼ | $-24.42M ▼ | $29.98M ▼ |
| Q2-2025 | $26.55M ▼ | $36.22M ▲ | $-2.27M ▼ | $-47.47M ▼ | $-13.31M ▲ | $33.95M ▲ |
| Q1-2025 | $26.65M ▲ | $7.27M ▼ | $-1.75M ▲ | $-20.05M ▼ | $-13.79M ▼ | $5.52M ▼ |
| Q4-2024 | $23.59M | $56.05M | $-2.6M | $-12.32M | $39.19M | $53.45M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
Engineering And Other Scientific | $110.00M ▲ | $120.00M ▲ | $120.00M ▲ | $250.00M ▲ |
Environmental And Health | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $40.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Exponent, Inc.'s financial evolution and strategic trajectory over the past five years.
Exponent combines steady revenue growth with high and resilient profitability, supported by strong cash generation and low capital intensity. Its balance sheet is conservative, with historically more cash than debt and growing retained earnings. The company operates in a defensible niche at the intersection of engineering, science, regulation, and litigation, where reputation, multidisciplinary expertise, and specialized testing facilities create meaningful barriers to entry. Consistent free cash flow has enabled rising dividends and shareholder returns without compromising core operations.
Key risks include a gradual tightening of liquidity as cash cushions shrink and leverage ticks up from very low levels, even if overall debt remains manageable. Margins at the project level have shown some pressure from rising delivery costs, and the absence of explicit R&D spending could become a concern if it signals underinvestment in new capabilities. The business is heavily dependent on the recruitment and retention of highly skilled experts, making talent a structural vulnerability. Demand can also fluctuate with litigation trends, regulatory shifts, and client budgets for risk and safety‑related consulting. Finally, any damage to the firm’s hard‑won reputation for objectivity and technical rigor would be difficult to repair.
The overall outlook appears favorable but not without caveats. Exponent is well placed to benefit from growing technological complexity, stricter regulation, and heightened focus on safety and reliability in areas like electrification, AI, digital health, and advanced energy systems. Its financial profile provides resilience and flexibility to invest in people and capabilities, even as the balance sheet becomes slightly less conservative. Future performance will hinge on maintaining strong margins, managing liquidity prudently, and continuing to deepen its expertise in emerging technologies. While past trends point to a stable, high‑quality business, outcomes will still depend on external factors such as regulatory environments, litigation volumes, and the pace of technological change in its end markets.

CEO
Catherine Ford Corrigan
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2018-06-08 | Forward | 2:1 |
| 2015-06-05 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 190
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:6.16M
Value:$448.65M
BLACKROCK INC.
Shares:5.99M
Value:$435.73M
VANGUARD GROUP INC
Shares:5.25M
Value:$382.15M
Summary
Showing Top 3 of 518

